Abstract
The activity and pulmonary metabolism of two peptides, 7‐homo Pro‐bradykinin and 8‐homo Phe‐bradykinin were studied in isolated systems. Both analogues were about 50–70 times less active than bradykinin on the guinea‐pig ileum and 70–160 times less active on isolated strips of cat terminal ileum. The action of both analogues on guinea‐pig ileum was potentiated (2.5‐3.0 fold) by a bradykinin potentiating peptide (BPP9a) but less so than the action of bradykinin (4–5 fold). Like bradykinin, the 8‐homo Phe analogue was extensively inactivated (>90%) in a single passage through the pulmonary circulation of guinea‐pig or rat isolated lungs and this inactivation was prevented by pre‐treatment of the lungs with BPP9a. The 7‐homo Pro analogue was inactivated to a lesser degree in guinea‐pig lungs (58%) and in rat lungs (89%) and its inactivation was not affected by BPP9a. It is concluded that the 8‐homo Phe analogue is a substrate for the dipeptidylcarboxypeptidase (angiotensin I converting enzyme) of lung, whereas the 7‐homo Pro analogue is not a substrate. There is about four times as much dipeptidylcarboxypeptidase activity in guinea‐pig isolated lungs as there is in rat isolated lungs.

This publication has 12 references indexed in Scilit: